Losses from “Embargo
Against Cuba”
Strategic Gains Through Normalization”
Area of Impact With the ‘Embargo Against Cuba’ (U.S. Losses) Without the Embargo (U.S. Strategic Gains)
Agriculture
Exclusion from a
$2.3B/year agricultural market
$1.8B–$2.3B/year in U.S. food exports
Pharmaceuticals &
Health No access to Cuban biotech & vaccines (e.g., Soberana-Plus)
Tourism & Aviation
$1.3B/year in lost revenue for airlines and cruise lines
Renewable Energy China/EU invested
$700M/year in codeveloped products & shared R&D
$1.2B–$1.5B/year in tourism and travelrelated earnings
$1.2B in solar and wind projects (U.S. excluded) Regional leadership in clean energy transition
Strategic Wake-Up Call
For decades, the embargo has been sold as a tool of strength, but in today’s dynamic world, it has become a tool of self-sabotage. While its geopolitical rivals and its own supposed strategic allies secure alliances and long-term gains in Cuba, the United States is actively isolating itself from its continental neighbor. Every year this policy remains, it costs American taxpayers billions, sidelines innovators, weakens economic influence, and accelerates the erosion of regional leadership.
The embargo is no longer a lever of pressure. It is a monument to missed opportunity—paid for by the very Americans it hurts the most.